MedTrace Logo

Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma

NCT03395379 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2018-01-10

No results posted yet for this study

Summary

The investigators aimed to evaluate the feasibility and safety of using ambient air to protect against thermal injury during RadioFrequency Ablation (RFA) for Renal Cell Carcinoma (RCC) based on data from cases at their institute.

Conditions

  • Unrecognized Condition

Interventions

PROCEDURE

RFA

Radiofrequency ablation (RFA) is a medical procedure in which part of the electrical conduction system of the tumor is ablated using the heat generated from medium frequency alternating current.

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-11
Primary Completion
2016-03-15
Completion
2016-05-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03395379 on ClinicalTrials.gov